BCL2 and Miyoshi myopathy: In MM, however, both ABT-737 and -199 are only highly effective against one molecular subgroup with a neutral prognostic value, namely the CCND1 subgroup, of which the MM cells present a Bcl-2high/Mcl-1low profile and depend on Bcl-2 for survival [10-12].